Forbion

Boston, Massachusetts

Firm Location:Boston, Massachusetts • Munich, Germany • Amsterdam, Netherlands • Netherlands • Denmark • Copenhagen, Denmark • United Kingdom • Naarden, Netherlands

Investor Firms That Co-Invest with Forbion

New Enterprise Associates (NEA)Atlas Venture Polaris Partners General Atlantic Versant Ventures Pfizer Venture Investments Novartis Venture Fund F-Prime Capital Partners Arcus Ventures RA Capital Management U.S. Venture Partners (USVP)High-Tech Gründerfonds ARCH Venture Partners Third Rock Ventures OrbiMed INKEF Capital Ysios Capital 5am Ventures Novo Holdings Seventure Partners Nextech Invest Longwood Fund Sanofi Ventures Pontifax Venture Capital Sofinnova Investments Andera Partners 4See Ventures Pure Imagination Brands Cambridge Innovation Capital BGV (BioGeneration Ventures)Advent Life Sciences Access Industries Red Tree Venture Capital Seroba Life Sciences Sofinnova Partners Self-employed The Founders Fund Polaris Venture Partners Hotmail RiverVest Venture Partners RTW Investments, LP EQT Group Nan Fung Life Sciences AgeChem Aglaia Oncology Funds IDF Financial Services, Financial Technology, and Business Services Life Sciences Partners J.P. Morgan Asset Management Alex & Thiago SpectraWAVE, Inc.

Forbion Team

Philip Astley-Sparke

Forbion·Venture Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Boston (MA)

to see your intro paths to Philip

Juliette Audet

Forbion·Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Netherlands

Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A)

to see your intro paths to Juliette

Marco Boorsma

Forbion·General Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Naarden (Netherlands), Investors in Amsterdam (Netherlands)

Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Manufacturing (Seed), Investors in Manufacturing (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A)

to see your intro paths to Marco

Jasper Bos

Forbion·General Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Amsterdam (Netherlands)

Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)

to see your intro paths to Jasper

Antoine Boulanger Piette

Forbion·Principal

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Amsterdam (Netherlands)

Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)

to see your intro paths to Antoine

Audrey Cacaly

Forbion·Principal

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Netherlands

Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)

to see your intro paths to Audrey

Dmitrij Hristodorov

Forbion·General Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Munich (Germany)

to see your intro paths to Dmitrij

Wouter Joustra

Forbion·General Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Amsterdam (Netherlands)

Investors in BioTech (Series B)

to see your intro paths to Wouter

Dirk Kersten

Forbion·Managing Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Amsterdam (Netherlands)

Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)

to see your intro paths to Dirk

Nanna Luneborg

Forbion·General Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Denmark

Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B)

to see your intro paths to Nanna

Geert-Jan Mulder

Forbion·Managing Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Naarden (Netherlands)

Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)

to see your intro paths to Geert-Jan

Holger Reithinger

Forbion·Advisor

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Munich (Germany)

Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)

to see your intro paths to Holger

Sander Slootweg

Forbion·Managing Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Netherlands

to see your intro paths to Sander

Marc-Olivier Turgeon

Forbion·Senior Associate

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Amsterdam (Netherlands)

Investors in BioTech (Seed), Investors in BioTech (Series A)

to see your intro paths to Marc-Olivier

Martien van Osch

Forbion·Managing Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Amsterdam (Netherlands)

to see your intro paths to Martien

Alice Vickers

Forbion·Advisor

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in United Kingdom

to see your intro paths to Alice

Matthias Vinther

Forbion·Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Copenhagen (Denmark)

Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in BioTech (Pre-seed)

to see your intro paths to Matthias